Some of the people that have called in are institutional type folks...I have done the research...And you are making a false assumption....The company is incredibly forthright and maybe way too much so as Couch has noted..
The truth is that the OTC market does not attract the smartest most experienced investors...They don't understand how things work and create a very unstable investor base subject to manipulation and foolishness. Elite is the best example of this as noted by how undervalued and manipulated it is.
A good example is that it has been non retail heavily manipulating and controlling the price for the past month or longer.
And I still have issue with Nasrat clearly stating that Isa... would be launched by the end of the year. Why even say that if its not going to take place. Clearly, he comes with lots of experience in multiple senior mgmnt. roles and he ought to have known that investors start to lose faith if timelines aren't meant. As far as the FDA and ART products, I can understand that we're on FDA time, but what about the generic product that was promised.
News 
Market Data 
Discover 
